Your browser doesn't support javascript.
loading
Optimization of Timing and Times for Administration of Atorvastatin-Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction.
Xu, Jun; Xiong, Yu-Yan; Li, Qing; Hu, Meng-Jin; Huang, Pei-Sen; Xu, Jun-Yan; Tian, Xia-Qiu; Jin, Chen; Liu, Jian-Dong; Qian, Li; Yang, Yue-Jin.
Afiliación
  • Xu J; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Xiong YY; McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.
  • Li Q; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.
  • Hu MJ; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Huang PS; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Xu JY; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Tian XQ; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Jin C; McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.
  • Liu JD; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.
  • Qian L; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Yang YJ; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Stem Cells Transl Med ; 8(10): 1068-1083, 2019 10.
Article en En | MEDLINE | ID: mdl-31245934
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Madre Mesenquimatosas / Atorvastatina / Infarto del Miocardio Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Stem Cells Transl Med Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Madre Mesenquimatosas / Atorvastatina / Infarto del Miocardio Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Stem Cells Transl Med Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido